论文部分内容阅读
轮状病毒疫苗在2007获准在以色列使用,而且在2011年五价疫苗(RV5)被引入以色列的国家免疫计划。确定轮状病毒疫苗对以色列南部5岁以下犹太和贝都因儿童因轮状病毒性胃肠炎(RVGE)和全因腹泻医院就诊发生率的影响。作者进行了一项以人群为基础,前瞻性,观察性研究。对2006到2013的数据进行了分析。作者的医院是该地区唯一的医疗中心,能够用年龄发病率进行计算。
The rotavirus vaccine was approved for use in Israel in 2007 and was introduced into Israel’s national immunization program in 2011 for the pentavalent vaccine (RV5). To determine the impact of rotavirus vaccine on the incidence of visits to hospital for rotavirus gastroenteritis (RVGE) and all-cause diarrhea in children under 5 years old in the Jewish and Bedouin fields in southern Israel. The authors conducted a population-based, prospective, observational study. The data from 2006 to 2013 were analyzed. The author’s hospital is the only medical center in the area and can be calculated using age-related morbidity.